Deadline: 4 June 2020

Topic:

Alignament of national, regional research funding programmes on translational cancer research

Programme:

Horizon 2020 SC1 "Health, demographic change and wellbeing"
Priority 1.1: Personalised Medicine

Funding rate:

EUR 5 million

Status: Closed

Topic:
Alignament of national, regional research funding programmes on translational cancer research

Who can participate:

Programme:
Horizon 2020 SC1 "Health, demographic change and wellbeing" Priority 1.1: Personalised Medicine

Consortium:

Status: Open

Total budget:
EUR 5 million

Funding rate:

Notes:
Scope: Alignament of national, regional research funding programmes on translational cancer research Impact: - Identification of common research and innovation priorities, taking into account international developments where relevant. - Leveraged funding, through transnational collaborative research and innovation on cancer, based on a common strategic research agenda - Demonstrated sharing of data and analyses of funded cancer research and their impact